The Toll like receptor 4 ligand cold-inducible RNA-binding protein as vaccination platform against cancer

Tumor infiltrating lymphocytes have been associated with a better prognostic and with higher response rates in patients treated with checkpoint inhibiting antibodies, suggesting that strategies promoting tumor inflammation may enhance the efficacy of these currently available therapies. Our aim was...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncoimmunology
Main Authors: Villanueva, Lorea, Silva, Leyre, Llopiz, Diana, Ruiz, Marta, Iglesias, Tamara, Lozano, Teresa, Casares, Noelia, Hervas-Stubbs, Sandra, Rodríguez, María José, Carrascosa, José L., Lasarte, Juan José, Sarobe, Pablo
Formato: Artigo
Idioma:Inglês
Publicado: Taylor & Francis 2017
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5889285/
https://ncbi.nlm.nih.gov/pubmed/29632721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1409321
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares